Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs ALEMBIC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON ALEMBIC BIOCON /
ALEMBIC
 
P/E (TTM) x 19.7 28.2 69.9% View Chart
P/BV x 1.8 1.0 174.3% View Chart
Dividend Yield % 0.6 2.6 21.6%  

Financials

 BIOCON    ALEMBIC
EQUITY SHARE DATA
    BIOCON
Mar-23
ALEMBIC
Mar-23
BIOCON /
ALEMBIC
5-Yr Chart
Click to enlarge
High Rs38887 445.7%   
Low Rs19256 345.1%   
Sales per share (Unadj.) Rs93.15.0 1,878.2%  
Earnings per share (Unadj.) Rs5.43.1 170.6%  
Cash flow per share (Unadj.) Rs14.63.4 430.0%  
Dividends per share (Unadj.) Rs1.502.20 68.2%  
Avg Dividend yield %0.53.1 16.8%  
Book value per share (Unadj.) Rs146.580.9 181.1%  
Shares outstanding (eoy) m1,200.60256.78 467.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.114.4 21.6%   
Avg P/E ratio x54.122.7 238.3%  
P/CF ratio (eoy) x19.821.0 94.5%  
Price / Book Value ratio x2.00.9 224.5%  
Dividend payout %28.070.1 40.0%   
Avg Mkt Cap Rs m347,81418,298 1,900.8%   
No. of employees `000NANA-   
Total wages/salary Rs m21,810240 9,071.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m111,7421,272 8,781.8%  
Other income Rs m7,681643 1,195.2%   
Total revenues Rs m119,4231,915 6,236.0%   
Gross profit Rs m16,611297 5,588.4%  
Depreciation Rs m11,13167 16,556.6%   
Interest Rs m4,1905 90,107.5%   
Profit before tax Rs m8,971868 1,033.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,54162 4,112.3%   
Profit after tax Rs m6,430806 797.6%  
Gross profit margin %14.923.4 63.6%  
Effective tax rate %28.37.1 397.9%   
Net profit margin %5.863.4 9.1%  
BALANCE SHEET DATA
Current assets Rs m123,3401,721 7,165.3%   
Current liabilities Rs m85,107838 10,154.6%   
Net working cap to sales %34.269.4 49.3%  
Current ratio x1.42.1 70.6%  
Inventory Days Days1295,038 2.6%  
Debtors Days Days117673 17.4%  
Net fixed assets Rs m394,07820,324 1,938.9%   
Share capital Rs m6,003514 1,168.9%   
"Free" reserves Rs m169,92620,267 838.4%   
Net worth Rs m175,92920,780 846.6%   
Long term debt Rs m152,9050-   
Total assets Rs m517,41822,046 2,347.0%  
Interest coverage x3.1187.7 1.7%   
Debt to equity ratio x0.90-  
Sales to assets ratio x0.20.1 374.2%   
Return on assets %2.13.7 55.8%  
Return on equity %3.73.9 94.2%  
Return on capital %4.04.2 95.3%  
Exports to sales %3.11.2 251.7%   
Imports to sales %6.02.4 253.4%   
Exports (fob) Rs m3,46716 22,111.0%   
Imports (cif) Rs m6,65430 22,254.2%   
Fx inflow Rs m3,46716 22,111.0%   
Fx outflow Rs m6,65430 22,254.2%   
Net fx Rs m-3,187-14 22,412.1%   
CASH FLOW
From Operations Rs m18,525389 4,768.0%  
From Investments Rs m-142,81873 -195,748.4%  
From Financial Activity Rs m130,487-464 -28,129.5%  
Net Cashflow Rs m6,411-2 -267,125.0%  

Share Holding

Indian Promoters % 40.4 70.9 56.9%  
Foreign collaborators % 20.3 0.0 -  
Indian inst/Mut Fund % 21.1 0.9 2,240.4%  
FIIs % 6.6 0.9 736.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 29.1 135.2%  
Shareholders   434,339 94,012 462.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Biocon vs ALEMBIC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Biocon vs ALEMBIC Share Price Performance

Period Biocon ALEMBIC S&P BSE HEALTHCARE
1-Day 2.92% 4.34% 1.18%
1-Month -2.53% -14.48% -0.75%
1-Year 30.52% 48.73% 61.82%
3-Year CAGR -13.55% -6.26% 18.16%
5-Year CAGR -2.73% 14.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the Biocon share price and the ALEMBIC share price.

Moving on to shareholding structures...

The promoters of Biocon hold a 60.6% stake in the company. In case of ALEMBIC the stake stands at 70.9%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Biocon and the shareholding pattern of ALEMBIC.

Finally, a word on dividends...

In the most recent financial year, Biocon paid a dividend of Rs 1.5 per share. This amounted to a Dividend Payout ratio of 28.0%.

ALEMBIC paid Rs 2.2, and its dividend payout ratio stood at 70.1%.

You may visit here to review the dividend history of Biocon, and the dividend history of ALEMBIC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.